View in EDS

1157P Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival.

Saved in:
Bibliographic Details
Title: 1157P Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival.
Authors: Verheijden, R.J.1 (AUTHOR), Janssen, J.C.2 (AUTHOR), Putker, A.E.3 (AUTHOR), Veenstra, S.P.G.R.4 (AUTHOR), Hospers, G.A.P.5 (AUTHOR), Aarts, M.J.B.6 (AUTHOR), Hehenkamp, K.W.7 (AUTHOR), Doornebosch, V.L.E.8 (AUTHOR), Verhaert, M.9 (AUTHOR), Van den Berkmortel, F.W.P.J.10 (AUTHOR), Burgers, F.H.11 (AUTHOR), Haanen, J.B.A.G.11 (AUTHOR), Piersma, D.8 (AUTHOR), Kapiteijn, E.7 (AUTHOR), Labots, M.4 (AUTHOR), Boers-Sonderen, M.J.3 (AUTHOR), Van der Veldt, A.A.M.2 (AUTHOR), Aspeslagh, S.9 (AUTHOR), May, A.M.12 (AUTHOR), Suijkerbuijk, K.P.M.1 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS690-S691. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2023.09.2291